At Memory Center, our mission is to provide compassionate and comprehensive medical care to all of our patients. Our board-certified neurologist, Dr. Michael Heublum, conducts
Mental assessment for Alzheimer's disease typically involves cognitive tests and neurological evaluations to detect memory loss and other impairments in thinking skills. These assessments help distinguish Alzheimer's from other forms of dementia and aid in early diagnosis and management of the disease.
Genetic testing for Alzheimer's disease involves analyzing specific genes known to increase the risk of developing the condition, such as APOE-e4. This type of testing can help assess an individual's genetic predisposition to Alzheimer's, but it does not definitively predict the onset of the disease.
Blood tests for Alzheimer's disease are emerging as a potential method for early detection, identifying biomarkers associated with the disease's pathology. These tests aim to provide a less invasive, more accessible alternative to traditional diagnostic methods like brain imaging and cerebrospinal fluid analysis.
MRI and PET scans are instrumental in the diagnosis of Alzheimer's disease, providing detailed images of the brain to detect structural and functional changes. These imaging techniques help identify atrophy, particularly in the hippocampus, and the presence of amyloid plaques, both hallmarks of Alzheimer's pathology.
LEQEMBI is a prescription medicine used to treat people with Alzheimer’s disease.
In a large, 18-month study:
Treatment with LEQEMBI was proven to slow the progression of early Alzheimer's disease, helping people remember, solve problems, and complete daily activities for longer.